These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11101085)

  • 1. Thresholds of CD4 cells for initiating trimethoprim-sulfamethoxazole prophylaxis in west Africa.
    Anglaret X; Toure S; Ouassa T; Dabis F; N'Dri-Yoman T
    AIDS; 2000 Nov; 14(16):2628-9. PubMed ID: 11101085
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
    Wiktor SZ; Sassan-Morokro M; Grant AD; Abouya L; Karon JM; Maurice C; Djomand G; Ackah A; Domoua K; Kadio A; Yapi A; Combe P; Tossou O; Roels TH; Lackritz EM; Coulibaly D; De Cock KM; Coulibaly IM; Greenberg AE
    Lancet; 1999 May; 353(9163):1469-75. PubMed ID: 10232312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.
    Anglaret X; Chêne G; Attia A; Toure S; Lafont S; Combe P; Manlan K; N'Dri-Yoman T; Salamon R
    Lancet; 1999 May; 353(9163):1463-8. PubMed ID: 10232311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary problems in African HIV-1-infected adults, Abidjan, Côte d'Ivoire. COTRIMO-CI Study Group.
    Castetbon K; Anglaret X; Attia A; Mahassadi A; Malvy D; Dabis F
    J Acquir Immune Defic Syndr; 2000 Apr; 23(4):357-8. PubMed ID: 10836761
    [No Abstract]   [Full Text] [Related]  

  • 5. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
    Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
    Goldie SJ; Yazdanpanah Y; Losina E; Weinstein MC; Anglaret X; Walensky RP; Hsu HE; Kimmel A; Holmes C; Kaplan JE; Freedberg KA
    N Engl J Med; 2006 Sep; 355(11):1141-53. PubMed ID: 16971720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
    Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA;
    AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.
    Lim L ; Street AC; Lewin SR
    AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267
    [No Abstract]   [Full Text] [Related]  

  • 9. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
    Mammen-Tobin A; Monteiro EF
    Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Côte d'Ivoire.
    Castetbon K; Anglaret X; Touré S; Chêne G; Ouassa T; Attia A; N'Dri-Yoman T; Malvy D; Salamon R; Dabis F;
    Am J Epidemiol; 2001 Jul; 154(1):75-84. PubMed ID: 11427407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Compliance in HIV infected adults. Study of opportunistic infection prophylaxis with cotrimoxazole in Ivory Coast].
    Gourvellec G; Anglaret X; Touré S; Huët C; Dakoury-Dogbo N; Lafont S; N'Dri-Yoman T; Chêne G; Salamon R;
    Presse Med; 2004 May; 33(9 Pt 1):595-600. PubMed ID: 15226691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should cotrimoxazole prophylaxis be taken by all adults with HIV in Africa?
    Mermin J; Lule JR; Ekwaru JP; Pitter C
    AIDS; 2005 May; 19(8):845-6. PubMed ID: 15867506
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of co-trimoxazole for urinary tract infections in developing countries.
    Leblebicioglu H; Ozaras R; Sunbul M
    Lancet Infect Dis; 2015 Jul; 15(7):764-5. PubMed ID: 26122444
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
    Quah SP; McBride M
    Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire.
    Anglaret X; Messou E; Ouassa T; Toure S; Dakoury-Dogbo N; Combe P; Mahassadi A; Seyler C; N'Dri-Yoman T; Salamon R;
    AIDS; 2003 Mar; 17(4):575-84. PubMed ID: 12598778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cotrimoxazole on hematologic parameters in HIV-infected adults in a community-based clinic in Entebbe, Uganda.
    Watera C; Todd J; Mutonyi G; Miiro G; Mpendo J; Hughes P; Nakiyingi-Miiro J; Whitworth J; Grosskurth H
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):369-71. PubMed ID: 18090300
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of trimethoprim-sulfamethoxazole prophylaxis on etiology and susceptibilities of pathogens causing human immunodeficiency virus-associated bacteremia.
    Wininger DA; Fass RJ
    Antimicrob Agents Chemother; 2002 Feb; 46(2):594-7. PubMed ID: 11796387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Anglaret X; Yazdanpanah Y; Wang B; Toure S; Seage GR; N'Dri-Yoman T; Walensky RP; Dakoury-Dogbo N; Goldie SJ; Messou E; Weinstein MC; Deuffic-Burban S; Salamon R; Freedberg KA
    S Afr Med J; 2006 Jun; 96(6):526-9. PubMed ID: 16841136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV.
    van Oosterhout JJ; Laufer MK; Graham SM; Thumba F; Perez MA; Chimbiya N; Wilson L; Chagomerana M; Molyneux ME; Zijlstra EE; Taylor TE; Plowe CV
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):626-31. PubMed ID: 16044018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in infants and children born to women infected with human immunodeficiency virus.
    Wilfert CM; Masur H; Gross PA; Kaplan JE; Holmes KK; Phair JP; Simonds RJ
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S132-3. PubMed ID: 8547506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.